Sunday, May 31
Sunday, May 31, 2026
Everything we published on this day.
2 picks
balance sheets Mother of All Reviews (Part Deux)
ZoomD fell 49% since April after Q1 revenue dropped 64% and it posted a $640,000 loss, leaving customer concentration and its $31 million…
Wolf's Substack
earnings The last Bristol Myers' blog post was wrong on the core thesis
Ivonescimab plus chemotherapy extended median overall survival by 4.2 months versus Tevimbra plus chemotherapy in HARMONI-6, challenging…
John Hempton's Newsletter